Breaking News

Qosina Introduces New Genderless AseptiQuik W Series Connectors

Designed for Large-volume, High-Flow Production environments.

By: Kristin Brooks

Managing Editor, Contract Pharma

Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, has introduced CPC’s (Colder Products Company) new AseptiQuik W Series connectors to its line of aseptic genderless connectors.
 
The new genderless AseptiQuik W Series connectors, with a 1 1/2” flow path, enable quick and easy sterile connections in large-volume, high-flow production and process intensification environments. The large diameter connection allows for higher flow rates, reducing the risk of flow restrictions or pressure drops that could negatively impact process performance.
 
The genderless design of the AseptiQuik is designed to simplify system integration and minimizes the risk of operator error. According to the company, the connectors’ robust construction provides reliable performance without the need for clamps or fixtures. 
 
Biopharmaceutical manufacturers can benefit from interchangeable 1”, 1 ¼” and 1 ½” flow solutions for full-scale bioprocessing production environments. 
 
The AseptiQuik W Series body is made of polycarbonate and is available in a high temperature (HT) version, suitable for autoclave or gamma irradiation applications. 
 
Part numbers:
·  AQW17016HT – AseptiQuik W Sterile Connector, High Temperature, Fits 1 inch ID Tubing 
(25.4 mm)
·  AQW17020HT – AseptiQuik W Sterile Connector, High Temperature, Fits 1 1/4 inch ID Tubing 
(1.25 inch, 31.75 mm)
·  AQW17024HT – AseptiQuik W Sterile Connector, High Temperature, Fits 1 1/2 inch ID Tubing 
(1.5 inch, 38.1 mm)
·  AQW33024HT – AseptiQuik W Sterile Connector, High Temperature, 1 1/2 inch Sanitary Flange
  
Qosina is a source for single-use bioprocess components, with low minimum orders, a liberal sampling policy and bill of material kitting, all supported by regulatory documentation and backed by Qosina’s assurance of supply.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters